Latest News Archive
Please select Category, Year, and then Month to display items
![]()
#UFSupdate (18 March 2020): UFS IMPLEMENTS MEASURES TO MINIMISE RISK OF COVID-19 TO STAFF
STATEMENT BY PROF FRANCIS PETERSEN, RECTOR AND VICE-CHANCELLOR
The executive management of the University of the Free State (UFS) welcomes the announcement of Dr Blade Nzimande, Minister of Higher Education, Science and Technology on 17 March 2020 that all post-school training institutions will have an early recess, starting on 18 March 2020. The Minister’s directive that universities should minimise risk of COVID-19 to all its staff during this time is also welcomed.
The announcement of Dr Nzimande is in line with the university’s decision on 16 March 2020 to suspend the academic programme as from 17 March 2020 and to resume it again on 14 April 2020.
It is important for us all to know that this is not business as usual, and that different thinking is required. Responsible citizenship is one of the crucial elements the world has increasingly been experiencing for the past few weeks. This is why we must act out our responsibility towards one another by focusing on ways in which social distancing can be achieved – especially during this low-risk period that South Africa is still experiencing. This is one of the reasons that informed the university’s decision on 16 March 2020 week to suspend the academic programme and also for students to vacate the residences by 20 March 2020.
The health and well-being of our staff members are equally important. The university’s Employee Task Team that was established on 16 March 2020 analysed options for the continuation of university operations during the recess period. These options were submitted to the executive management, discussed with the Chairperson of the UFS Council and approved on 18 March 2020.
Staff members who have children at school and pre-school may work from home on 19 and 20 March 2020. For the period 23 March 2020 to 13 April 2020, the number of staff members present on all three campuses will be reduced to a minimum and staff members may be allowed to work from home where practically possible.
Arrangements have been made to accommodate those staff members who are performing services which cannot be done from home (such as cleaning, gardening, maintenance, sports, etc) in a flexible and reasonable way. Similar arrangements will be made with office-based support services staff, prioritising institutional needs and based on humane and personal circumstances. Academic staff have been requested to ensure that the online learning materials are finalised and made available for the online learning platform.
The decision for employees to work from home is based on the premise that all employees are deemed to be at work from 23 March 2020 to 13 April 2020. This requires staff members to be available and contactable by line managers at all times during the university’s normal working hours.
I am comfortable that these measures will alleviate the concerns from our staff regarding the spreading of COVID-19 and the risk to themselves without compromising university operations.
Prof F W Petersen
Rector and Vice-Chancellor
University of the Free State
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004